‘I just don’t get it’: judge questions Sandoz cross claim in Lexapro patent case

Clayton Utz 2018-10-02 9:25 pm By Miklos Bolza | Sydney

Please login to bookmark

A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au